Equities

Nanalysis Scientific Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Nanalysis Scientific Corp

Actions
  • Price (CAD)0.155
  • Today's Change0.00 / 0.00%
  • Shares traded6.47k
  • 1 Year change-50.79%
  • Beta0.0871
Data delayed at least 15 minutes, as of Feb 10 2026 15:52 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nanalysis Scientific Corp. is a global manufacturer and seller of compact magnetic resonance imaging (MRI) and spectroscopy products. Its segments include Scientific Equipment and Security Services. The Scientific Equipment segment conducts scientific equipment manufacturing and sales, primarily as a patent-protected technology company that develops, manufactures, and sells magnetic resonance (MR) products for education, pharmaceutical, biotech, nutraceutical, chemical, food, materials, security, life science and medical applications. The Security Services segment focuses on providing security services, namely providing preventative and on-call maintenance services, as well as installation of detection and analysis equipment. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. The Company's devices are used in industries, including chemical, mining, pharma, and others.

  • Revenue in CAD (TTM)41.74m
  • Net income in CAD-12.38m
  • Incorporated2017
  • Employees130.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
VVT Med Inc9.49k-3.17m18.07m10.00------1,904.76-0.1048-0.10480.0005-0.01170.0072-------241.79437.87----71.43---33,401.511,850.650.6354-19.392.530.00----15.43------
Medx Health Corp522.91k-5.30m19.68m--------37.63-0.0187-0.01870.0018-0.03320.49080.865113.37---497.63-619.54----33.6045.55-1,013.97-858.590.0567-1.70----7.37-10.6620.25------
Nanalysis Scientific Corp41.74m-12.38m21.46m130.00--1.58--0.5141-0.1092-0.10920.36720.0980.96336.855.00---28.57-21.20-44.19-30.0426.9635.26-29.66-37.300.6242-2.410.6248--59.8240.3215.95---9.96--
VentriPoint Diagnostics Ltd175.62k-4.06m22.36m--------127.31-0.0248-0.02480.0011-0.02780.3207--1.04---741.44-109.11---191.330.0086.67-2,311.87-8,206.33---8.35----93.513.27-0.9776------
Aurora Spine Corp24.45m-1.82m24.32m13.00--4.74--0.9944-0.0233-0.02330.31390.06651.521.935.51---11.30-13.83-17.27-19.1959.7452.84-7.44-10.241.10-5.450.4836--20.959.5140.34--17.34--
Data as of Feb 10 2026. Currency figures normalised to Nanalysis Scientific Corp's reporting currency: Canadian Dollar CAD

Institutional shareholders

7.41%Per cent of shares held by top holders
HolderShares% Held
Pathfinder Asset Management Ltd.as of 30 Jun 20259.80m7.41%
Data from 30 Jun 2025 - 30 Jun 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.